Profile data is unavailable for this security.
About the company
Eurobio Scientific SA, formerly Diaxonhit, is a France-based biotechnology company engaged in the field of in-vitro diagnostic. It is engaged in activities ranging from discovery to the commercialization of specialty diagnostic products. The Company owns a portfolio of diagnostic products in three specialty areas: infectious diseases; Alzheimer's disease, and cancer. It consists of Tetanos Quick Stick (TQS), which is an unitary test enabling to determine the tetanus vaccination status. It has a portfolio of in-house and co-developed products, including AclarusDx (a blood-based test for the detection of biomarkers specific for Alzheimer's disease). The portfolio includes BJI Inoplex for prosthetic infections and EHT Dx14 for breast cancer (both in validation phase). The co-developed products include research programs for the identification of predictive biomarkers of response for anti-HER2 and anti-angiogenic therapies, among others. It operates through Genbio and Eurobio Capforce Plus.
- Revenue in EUR (TTM)144.25m
- Net income in EUR6.64m
- Incorporated1997
- Employees137.00
- LocationEurobio Scientific SALes Ulis CedexLES ULIS 91953FranceFRA
- Phone+33 1 169796480
- Fax+33 158054719
- Websitehttps://www.eurobio-scientific.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eurofins-Cerep SA | 42.42m | 7.25m | 97.35m | 218.00 | 13.42 | 1.44 | 10.53 | 2.30 | 1,438.10 | 1,438.10 | 8,415.76 | 13,378.57 | 0.5618 | 1.52 | 5.41 | 186,032.70 | 9.61 | 14.21 | 11.08 | 17.51 | 85.48 | 73.61 | 17.10 | 19.77 | 6.89 | -- | 0.0047 | -- | -7.47 | 11.60 | -33.72 | 14.64 | -- | -- |
| Maat Pharma SA | 2.57m | -24.14m | 108.56m | 50.00 | -- | 4.24 | -- | 42.23 | -2.03 | -2.03 | 0.2161 | 1.84 | 0.0511 | 6.50 | 2.18 | 51,420.00 | -47.94 | -35.49 | -64.64 | -42.98 | 67.87 | -- | -938.86 | -1,157.54 | 2.75 | -47.95 | 0.4014 | -- | 55.80 | -- | -43.78 | -- | 30.30 | -- |
| Transgene SA | 6.22m | -22.91m | 115.23m | 162.00 | -- | -- | -- | 18.53 | -0.2267 | -0.2267 | 0.0615 | -0.0061 | 0.124 | -- | 6.27 | 39,367.09 | -45.68 | -24.81 | -60.61 | -29.79 | -- | -- | -368.34 | -193.24 | -- | -- | 6.81 | -- | -23.68 | 1.51 | 31.94 | -- | 14.44 | -- |
| Cellectis SA | 33.63m | -97.33m | 124.27m | 235.00 | -- | 1.03 | -- | 3.70 | -1.37 | -1.08 | 0.3904 | 1.67 | 0.119 | -- | 6.23 | 143,092.00 | -35.11 | -24.08 | -53.69 | -30.69 | -- | -64.64 | -294.96 | -308.24 | -- | -2.77 | 0.452 | -- | -64.26 | -15.57 | -20.55 | -- | -26.15 | -- |
| Innate Pharma SA | 24.85m | -34.05m | 130.36m | 168.00 | -- | 4.53 | -- | 5.25 | -0.4215 | -0.4215 | 0.3078 | 0.3557 | 0.1418 | -- | 14.93 | 138,826.80 | -19.43 | -8.83 | -24.80 | -12.11 | 88.00 | 93.17 | -137.03 | -55.55 | -- | -- | 0.7527 | -- | 4.68 | -8.27 | 86.94 | -- | 10.50 | -- |
| Adocia SA | 523.00k | -20.72m | 141.92m | 79.00 | -- | -- | -- | 271.36 | -1.53 | -1.53 | 0.0382 | -0.5123 | 0.0234 | 1.15 | 3.15 | 6,705.13 | -92.78 | -43.08 | -- | -72.93 | 32.50 | -- | -3,960.99 | -514.53 | 0.8927 | -2.79 | 2.38 | -- | -81.22 | -46.13 | -206.65 | -- | -27.60 | -- |
| Nanobiotix SA | 36.22m | -33.47m | 186.37m | 102.00 | -- | -- | -- | 5.15 | -0.763 | -0.763 | 0.8429 | -0.4594 | 0.57 | -- | 17.20 | 355,107.80 | -52.68 | -54.11 | -323.15 | -80.68 | -- | -- | -92.42 | -756.15 | -- | -2.42 | 1.87 | -- | -- | 203.88 | 30.40 | -- | -7.81 | -- |
| Inventiva SA | 15.62m | -104.19m | 211.60m | 123.00 | -- | -- | -- | 13.55 | -2.08 | -2.08 | 0.3104 | -1.51 | 0.2833 | -- | 10.30 | 139,437.50 | -185.05 | -54.30 | -839.50 | -69.98 | -- | -- | -653.15 | -669.97 | 0.586 | -12.21 | -- | -- | 43.50 | 40.46 | -103.46 | -- | -0.33 | -- |
| Sensorion SA | 0.00 | -23.67m | 213.96m | 61.00 | -- | 2.56 | -- | -- | -0.1048 | -0.1048 | 0.00 | 0.2777 | 0.00 | -- | -- | 0.00 | -36.68 | -35.12 | -47.21 | -46.97 | -- | -- | -- | -- | -- | -- | 0.0274 | -- | -- | -- | 4.94 | -- | 126.45 | -- |
| Ose Immunotherapeutics SA | 83.44m | 46.03m | 216.00m | 52.00 | 4.36 | 2.65 | 4.37 | 2.59 | 2.27 | 2.27 | 4.10 | 3.74 | 0.7541 | -- | 32.09 | 1,517,127.00 | 41.60 | -17.17 | 49.66 | -20.55 | -- | -- | 55.17 | -94.71 | -- | 9.24 | 0.3502 | -- | -87.83 | -38.07 | -29.52 | -- | -17.11 | -- |
| Genfit SA | 84.00m | 22.27m | 244.20m | 169.00 | 14.37 | 2.50 | 10.26 | 2.91 | 0.3404 | 0.3404 | 1.53 | 1.95 | 0.4322 | 543.50 | 2.61 | 528,308.20 | 11.46 | -12.57 | 14.53 | -15.30 | 97.41 | 94.96 | 26.51 | -76.23 | 3.74 | 9.33 | 0.4105 | -- | 43.70 | 38.49 | -21.82 | -- | -3.27 | -- |
| Eurobio Scientific SA | 144.25m | 6.64m | 263.91m | 137.00 | 40.99 | -- | 14.50 | 1.83 | 0.6282 | 0.6282 | 13.50 | -- | -- | -- | -- | 1,052,883.00 | -- | 16.91 | -- | 21.53 | 46.81 | 50.95 | 4.61 | 23.34 | -- | 5.62 | -- | 0.00 | -14.81 | 20.80 | -80.61 | -- | 20.02 | -- |
| Valneva SE | 158.54m | -7.42m | 392.26m | 695.00 | -- | 1.54 | 9.02 | 2.47 | -0.057 | -0.057 | 1.13 | 1.56 | 0.3057 | 2.03 | 4.24 | 231,777.80 | -1.43 | -15.39 | -2.09 | -25.06 | 38.58 | 35.94 | -4.68 | -34.95 | 2.25 | 2.06 | 0.4806 | -- | -57.46 | 6.34 | 29.21 | -- | 35.18 | -- |
Data as of Nov 11 2024. Currency figures normalised to Eurobio Scientific SA's reporting currency: Euro EUR
3.85%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Oddo BHF Asset Management SASas of 02 Aug 2024 | 167.65k | 1.64% |
| MC Square SAas of 30 Jun 2024 | 50.37k | 0.49% |
| American Century Investment Management, Inc.as of 03 Oct 2024 | 27.70k | 0.27% |
| Groupama Asset Management SAas of 31 Jul 2024 | 26.24k | 0.26% |
| Talence Gestion SASas of 30 Aug 2024 | 24.86k | 0.24% |
| PROMEPAR Asset Management SAas of 30 Jul 2024 | 23.00k | 0.22% |
| Sunny Asset Management SAas of 25 Oct 2024 | 20.00k | 0.20% |
| Pure Capital SAas of 31 Dec 2023 | 20.00k | 0.20% |
| Financi�re Arbevel SAas of 30 Dec 2022 | 18.07k | 0.18% |
| UBS LA MAISON de Gestionas of 30 Dec 2022 | 16.71k | 0.16% |
More ▼
Data from 31 Dec 2023 - 25 Oct 2024Source: FactSet Research Systems Inc.
